Luzdivina Monteserín

ORCID: 0000-0002-2601-0739
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Esophageal and GI Pathology
  • Gastroesophageal reflux and treatments
  • Helicobacter pylori-related gastroenterology studies
  • Microscopic Colitis
  • Liver Disease and Transplantation
  • Celiac Disease Research and Management
  • Esophageal Cancer Research and Treatment
  • Pancreatitis Pathology and Treatment
  • Liver Disease Diagnosis and Treatment
  • Drug-Induced Hepatotoxicity and Protection
  • Gastric Cancer Management and Outcomes
  • Inflammatory Bowel Disease
  • Helminth infection and control
  • Histiocytic Disorders and Treatments
  • Hepatocellular Carcinoma Treatment and Prognosis
  • Liver Diseases and Immunity
  • Pancreatic and Hepatic Oncology Research
  • Eosinophilic Disorders and Syndromes
  • Gastrointestinal Tumor Research and Treatment
  • Gallbladder and Bile Duct Disorders
  • Biosimilars and Bioanalytical Methods
  • Tuberous Sclerosis Complex Research
  • Monoclonal and Polyclonal Antibodies Research
  • Poisoning and overdose treatments
  • Cancer Diagnosis and Treatment

Universidade de Santiago de Compostela
2018-2023

Servicio Gallego de Salud
2023

Complejo Hospitalario Universitario de Santiago
2018-2020

Instituto de Investigación Sanitaria de Santiago
2018-2019

Hospital de León
2015-2018

Complejo Asistencial Universitario de Palencia
2016-2018

In Europe, acute hepatitis caused by the E virus (HEV) traditionally was an infection found in people who had travelled to endemic zones, mainly Asia and Africa. However, a growing number of sporadic autochthonous cases are now being diagnosed Western world.To analyze HEV our setting, with identification clinical-epidemiological characteristics.We included (positive anti-HEV IgM and/or RNA present serum) between January 2008 December 2014. Different clinical, epidemiological evolutive...

10.17235/reed.2017.4258/2016 article EN publisher-specific-oa Revista Española de Enfermedades Digestivas 2017-01-01

Extra-hepatic spread is present in 5% to 15% of patients with hepatocellular carcinoma (HCC) at the time diagnosis. The most frequent sites are lung and regional lymph nodes. Here, we report 3 cases unsuspected HCC symptoms due bone lesions as initial presentation. Morphological characteristics immunohistochemistry from examined were key data for None had an already known chronic liver disease. Differential diagnoses upon ectopic disease or hepatoid adenocarcinoma shown. Therapy orally...

10.4254/wjh.v9.i29.1158 article EN World Journal of Hepatology 2017-10-16

Objectives Exocrine pancreatic insufficiency is a frequent and clinically relevant complication of cancer probably secondary to duct obstruction. We aimed at evaluating the impact endoscopic drainage on function in patients with unresectable cancer. Methods A double-blind, prospective, randomized, single-center, interventional study was designed. Patients undergoing retrograde cholangiopancreatography for jaundice were randomized biliary (group A) or biliopancreatic B). Pancreatic evaluated...

10.1097/mpa.0000000000001817 article EN Pancreas 2021-05-01

In celiac disease there is an increase of lymphocytes expressing FOXP3 in the intestinal mucosa associated with varying degrees villous atrophy. Our aim was to evaluate expression duodenal lymphocytic enteritis according aetiology and correlation T-γδ.We compared three adult patient groups suffering enteritis: celiacs following a gluten-free diet (n=12), first-degree relatives patients genetic risks (n=14) functional dyspepsia (n=14), along control group not from (n=16). The population...

10.14670/hh-11-888 article EN PubMed 2018-01-01

Background: Secondary loss of response (LOR) occurs in 23–46% when determined acording to dose intensification. Intensification treatment is effective about 60–90% the cases and switching non antiTNF drugs 19–68%. Immunogenicity not only factor affecting anti-TNF drug clearance efficacy. The assessment disease activity by measuring seric levels facilitates rational decisions on management LOR. Methods: Restrospective study our institution patients with ulcerative colitis (UC) or Crohn's (CD)...

10.1093/ecco-jcc/jjx002.561 article EN Journal of Crohn s and Colitis 2017-01-26

10.1016/j.med.2020.05.004 article ES Medicine - Programa de Formación Médica Continuada Acreditado 2020-04-01
Coming Soon ...